[心力衰竭中的远程医疗:证据,益处和未来前景]
Simon Glück1, Oliver Przibille2, Friedrich Köhler3
1BNK Service GmbH, Brabanter Str. 4, 80805, München, Deutschland. simon.glueck@bnk-service.de.
Herz
|January 22, 2026
概括
心力衰竭的远程监测 (TmHi) 现在是德国的标准,报销的护理,减少了住院治疗和死亡率. 尽管证明了好处,标准化和互操作性是未来改进这个不断发展的数字健康服务的关键领域.
科学领域:
- 心脏病学 心脏病学
- 数字健康数字健康
- 医疗保健服务研究 医疗服务研究
背景情况:
- 心力衰竭的远程监测 (TmHi) 从试点项目发展成为德国的结构化,报销的门诊服务.
- 来自试验和元分析的证据支持TmHi在减少死亡率和住院治疗方面的有效性.
- 通过远程医疗中心 (TMZ),TmHi促进了病情恶化的早期检测和主动管理.
研究的目的:
- 审查德国心力衰竭远程监测的现状和影响.
- 突出TmHi的临床,经济和系统重要性.
- 确定在TMHi实施中需要改进的领域.
主要方法:
- 随机对照试验和元分析的分析.
- 审查德国TmHi的法律,技术和组织标准.
- 评估当前的实践和跨远程医疗中心的异质性.
主要成果:
- TmHi是常规护理的全额补偿组成部分,有强有力的证据支持.
- 观察到死亡率,住院病例和改善的护理连续性的持续减少.
- 实施显示异质性,需要在工作流程,互操作性和人员配置方面进行标准化.
结论:
- 对心力衰竭的远程监测在临床上是有益的,并且在经济和系统上越来越重要.
- TmHi正在转变为预测性,数字集成的心力衰竭护理的基石.
- 需要进一步的标准化和优化来最大限度地发挥TmHi的潜力.
相关概念视频
Heart Failure II: Pathophysiology
790
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
790
Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
Heart Failure I: Introduction
729
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
729
Heart Failure VI: Adjunct Therapies
278
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
278
Heart Failure Drugs: Diuretics
825
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
825
Heart Failure V: Medical Management
227
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
227


